Bee venom by stings for treatment: of cerebral palsy

Bee venom sting therapy is the part of apitherapy which utilizes bee venom in the treatment of health conditions. It has been used since ancient times and in this mo1ern age as an alternative therapy to treat multiple sclerosis, Lyme disease, and chronic fatigue syndrome. This study aims to evaluate the benefit of using Bee venom sting in treatment of cerebral palsy. Between 2004 and 2007, 6 children with cerebral palsy [4 males and 2 females] continued their medical treatment, rehabilitation, assisted devices, and speech therapy, beside weekly Bee venom sting treatment according to the center program. The child was evaluated by clinical sheet proposed by department of neurosurgery, Faculty of medicine, Suez Canal University [Khalil cerebral palsy scale, table 1]. Khalil scale was 15 points where the child had evaluated with the maximum score of 15. This scale evaluated the clinical status and improvement every six months for the next three years. All cerebral palsy children during follow up had variable degree of improvement that was recorded using Khalil scale during research study period. Notably, those children with spastic or mild cerebral palsy showed much more improvement than those with ataxia and Dyskinesia [score of 8-13 comparative to 6-9 respectively]. Not only motor function but also speech, occupational, and intellectual function had variable degree of improvement. Use of Bee Venom stings in treatment of cerebral palsy children may improve the motor, occupational an intellectual function in those patients beside other standard medical treatment

Assessment of endoscopic uses in transnasal transsphenoidal Approaches for pituitary tumors

Transsphenoidal approaches usually are the preferred method for treatment of pituitary tumor because of a lower risk of complications. Microscope alone has been used in treatment of such tumor. Recently, with minimal invasive surgery, endoscope has been introduced as an alternative and effective tool in transsphenoidal surgery. This study aims to evaluate the benefit of endoscopic alone or assisted microscopic transnasal transsphenoidal surgeries for pituitary tumors. Between January 2004 and till March 2006, 50 patients [26 males and 24 females] were surgically treated in three departments of neurosurgery. Assisted endoscopic surgeries were done in 38 patients and 12 had direct endoscopic resection. The majority of pituitary tumors patients were macroadenomas in 94% and 58% were presented with sellar and suprasellar extension. The common pituitary tumor was non-secreting adenomas [58%], followed by prolactinomas [18%], and unexpected metastasis [10%], while the least was Cushing disease [2%] and poly hormonal adenoma [2%]. The long term outcome revealed 58% of patients showed remission, 34% improved, 8% had stationary course, and no one had worsen of his condition. The incidence of diabetes insipidus [DI] in this study was relatively high 18% and 6% developed persistent DI after surgery. No recurrence rate was reported during follow up. Uses of endoscope in endonasal transsphenoidal surgeries for pituitary tumors are safe and effective in radical resection of the tumor